These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8102621)

  • 21. Panic disorder and social phobia: current treatments and new strategies.
    Davidson JR; Connor KM; Sutherland SM
    Cleve Clin J Med; 1998; 65 Suppl 1():SI39-44; discussion SI45-7. PubMed ID: 12033205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of the selective serotonin reuptake inhibitors in the spectrum of anxiety.
    Kent JM; Coplan JD; Gorman JM
    Biol Psychiatry; 1998 Nov; 44(9):812-24. PubMed ID: 9807637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction. The multiplicity of uses of benzodiazepines.
    Lapierre YD
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S101. PubMed ID: 7905779
    [No Abstract]   [Full Text] [Related]  

  • 24. Serotonin in panic disorder and social phobia.
    Sheehan DV; Raj BA; Trehan RR; Knapp EL
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():63-77. PubMed ID: 7911142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
    Rickels K; Schweizer E; Csanalosi I; Case WG; Chung H
    Arch Gen Psychiatry; 1988 May; 45(5):444-50. PubMed ID: 2895993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of d-fenfluramine to benzodiazepines produces a marked improvement in refractory panic disorder--a case report.
    Hetem LA
    J Clin Psychopharmacol; 1996 Feb; 16(1):77-8. PubMed ID: 8834424
    [No Abstract]   [Full Text] [Related]  

  • 27. Generalized anxiety disorder versus panic disorder: participation in controlled efficacy trials.
    Mavissakalian MR; Zamar N
    Compr Psychiatry; 2000; 41(4):253-8. PubMed ID: 10929792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anxiety disorders: long-term treatment and replapse prevention].
    Bandelow VB; Wolff-Menzler C; Wedekind D; Rüther E
    MMW Fortschr Med; 2006 Jan; 148(4):31-4. PubMed ID: 16502797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The right drugs for panic and phobias. Managing anxiety in your patients].
    Stiefelhagen P
    MMW Fortschr Med; 2001 Sep; 143(37):16. PubMed ID: 11599286
    [No Abstract]   [Full Text] [Related]  

  • 30. Personality dimensions in panic disorder before and after effective treatment.
    Starcevic V; Uhlenhuth EH
    Anxiety; 1996; 2(2):95-8. PubMed ID: 9160608
    [No Abstract]   [Full Text] [Related]  

  • 31. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder.
    Roy-Byrne P; Russo J; Pollack M; Stewart R; Bystrisky A; Bell J; Rosenbaum J; Corrigan MH; Stolk J; Rush AJ; Ballenger J
    Psychol Med; 2003 Apr; 33(3):511-8. PubMed ID: 12701671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Panic disorder: the place of benzodiazepines and selective serotonin reuptake inhibitors.
    Kasper S; Resinger E
    Eur Neuropsychopharmacol; 2001 Aug; 11(4):307-21. PubMed ID: 11532386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes.
    Yonkers KA; Gilstad-Hayden K; Forray A; Lipkind HS
    JAMA Psychiatry; 2017 Nov; 74(11):1145-1152. PubMed ID: 28903165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
    Adams JB; Pyke RE; Costa J; Cutler NR; Schweizer E; Wilcox CS; Wisselink PG; Greiner M; Pierce MW; Pande AC
    J Clin Psychopharmacol; 1995 Dec; 15(6):428-34. PubMed ID: 8748432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aripiprazole as augmentation treatment of refractory generalized anxiety disorder and panic disorder.
    Hoge EA; Worthington JJ; Kaufman RE; Delong HR; Pollack MH; Simon NM
    CNS Spectr; 2008 Jun; 13(6):522-7. PubMed ID: 18567977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiety disorders: a comprehensive review of pharmacotherapies.
    Hoffman EJ; Mathew SJ
    Mt Sinai J Med; 2008; 75(3):248-62. PubMed ID: 18704983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy studies of alprazolam in panic disorder.
    Spiegel DA
    Psychopharmacol Bull; 1998; 34(2):191-5. PubMed ID: 9640999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalized anxiety disorder: raising the expectations of treatment.
    Allgulander C; Sheehan DV
    Psychopharmacol Bull; 2002; 36 Suppl 2():68-78. PubMed ID: 17450651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of the Stages of Change Scale in a clinical drug trial.
    Wilson M; Bell-Dolan D; Beitman B
    J Anxiety Disord; 1997; 11(4):395-408. PubMed ID: 9276784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.